Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay

European Respiratory Journal

Volumn 41, Issue 5, 2013, Pages 1163-1171

  Fitzwater, Sean Patrick ^a,d   Sechler, G Andrew ^a,e   Jave, Oswaldo ^b   Coronel, Jorge ^a   Mendoza, Alberto ^c   Gilman, Robert H ^e   Friedland, Jon S ^f   Moore, David A J ^a,d,f,g  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b MINISTERIO DE SALUD   (Peru)

^c INSTITUTO NACIONAL DE SALUD   (Peru)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Diagnostics; Extensively drug resistant tuberculosis; Multidrug resistance; Second line drug susceptibility testing; Tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY ASSAY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SPUTUM CULTURE; SURVIVAL RATE;

DIAGNOSTICS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG RESISTANCE; SECOND-LINE DRUG SUSCEPTIBILITY TESTING; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PERU; PHENOTYPE; ROC CURVE; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84874931336     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00059812     Document Type: Article

References (39)

1. WHO Global Tuberculosis Control Report 2010. Geneva, World Health Organization, 2010.
2. Multidrug and Extensively Drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. Geneva, World Health Organization, 2010.
3. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-1580. (Pubitemid 44780738)
4. Andrews JR, Gandhi NR, Moodley P, et al. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. J Infect Dis 2008; 198: 1582-1589.
5. Andrews JR, Shah NS, Gandhi N, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J Infect Dis 2007; 196: Suppl. 3, S482-S490. (Pubitemid 351417242)
6. Koenig R. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination. Science 2008; 319: 894-897. (Pubitemid 351263739)
7. Shah NS, Wright A, Bai GH, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 2007; 13: 380-387. (Pubitemid 46348124)
8. Strategic and Technical Advisory Group for Tuberculosis: Report on Conclusions and Recommendations. Seventh Meeting. Geneva, World Health Organization, 2007.
9. Raviglione MC, Smith IM. XDR tuberculosis - implications for global public health. N Engl J Med 2007; 356: 656-659.
10. Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355: 1539-1550. (Pubitemid 44547806)
11. Moore DA, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004; 42: 4432-4437. (Pubitemid 39362351)
12. Madison B, Robinson-Dunn B, George I, et al. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol 2002; 40: 3976-3979. (Pubitemid 35285776)
13. Luna-Herrera J, Martinez-Cabrera G, Parra-Maldonado R, et al. Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 2003; 22: 21-27. (Pubitemid 36286689)
14. Brady MF, Coronel J, Gilman RH, et al. The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis. J Vis Exp 2008; 18: 845.
15. Laboratory Services in TB control. Parts I, II, and III. WHO/tb/98.258. Geneva, World Health Organization, 1998.
16. Kubica GP, Dye WE, Cohn ML, et al. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis 1963; 87: 775-779.
17. Pfyffer GE, Bonato DA, Ebrahimzadeh A, et al. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol 1999; 37: 3179-3186. (Pubitemid 29455202)
18. Bastian I, Rigouts L, Palomino JC, et al. Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob Agents Chemother 2001; 45: 1934-1936. (Pubitemid 32466380)
19. Martin A, Camacho M, Portaels F, et al. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 2003; 47: 3616-3619. (Pubitemid 37345731)
20. Pracharktam R, Angkananukool K, Vibhagool A. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand. J Med Assoc Thai 2001; 84: 1241-1245. (Pubitemid 34136417)
21. Rusch-Gerdes S, Pfyffer GE, Casal M, et al. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical secondline drugs and newer antimicrobials. J Clin Microbiol 2006; 44: 688-692.
22. Kruuner A, Yates MD, Drobniewski FA. Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drugresistant clinical strains of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 811-818.
23. Caviedes L, Delgado J, Gilman RH. Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 1873-1874. (Pubitemid 34493180)
24. Huang TS, Tu HZ, Lee SS, et al. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems. Ann Clin Lab Sci 2002; 32: 142-147. (Pubitemid 34450515)
25. Caviedes L, Lee TS, Gilman RH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000; 38: 1203-1208. (Pubitemid 30140586)
26. Park WG, Bishai WR, Chaisson RE, et al. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 4750-4752. (Pubitemid 35434981)
27. Del Portillo P, Thomas MC, Martinez E, et al. Multiprimer PCR system for differential identification of mycobacteria in clinical samples. J Clin Microbiol 1996; 34: 324-328. (Pubitemid 26035104)
28. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
29. Canetti G, Froman S, Grosset J, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-578.
30. Adjers-Koskela K, Katila ML. Susceptibility testing with the manual Mycobacteria Growth Indicator Tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis. J Clin Microbiol 2003; 41: 1235-1239. (Pubitemid 36307133)
31. Fegou E, Jelastopulu E, Nicolaou S, et al. Comparison of the manual Mycobacteria Growth Indicator tube and the Etest with the method of proportion for susceptibility testing of Mycobacterium tuberculosis. Chemotherapy 2006; 52: 174-177. (Pubitemid 43882415)
32. Siddiqi SH, Hawkins JE, Laszlo A. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol 1985; 22: 919-923. (Pubitemid 16222713)
33. Roberts GD, Goodman NL, Heifets L, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983; 18: 689-696. (Pubitemid 13004221)
34. Bergmann JS, Woods GL. Reliability of mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin. J Clin Microbiol 1997; 35: 3325-3327. (Pubitemid 27505773)
35. Parsons LM, Somoskovi A, Urbanczik R, et al. Laboratory diagnostic aspects of drug resistant tuberculosis. Front Biosci 2004; 9: 2086-2105.
36. McDermott W, Tompsett R. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc 1954; 70: 748-754.
37. Butler WR, Kilburn JO. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother 1983; 24: 600-601. (Pubitemid 13021442)
38. Salfinger M, Heifets LB. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob Agents Chemother 1988; 32: 1002-1004.
39. Kam KM, Sloutsky A, Yip CW, et al. Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance. Int J Tuberc Lung Dis 2010; 14: 282-288.